{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:18:11Z","timestamp":1790381891754,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.idc.2020.10.003","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T19:02:13Z","timestamp":1607367733000},"page":"81-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Staphylococcal Skin and Soft Tissue Infections"],"prefix":"10.1016","volume":"35","author":[{"given":"Timothy J.","family":"Hatlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren G.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.idc.2020.10.003_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2020.10.003_bib2","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry acute bacterial skin and skin structure infections: developing drugs for treatment. Available at: http:\/\/https:\/\/www.fda.gov\/files\/drugs\/published\/Acute-Bacterial-Skin-and-Skin-Structure-Infections---Developing-Drugs-for-Treatment.pdf. Published Oct 2013. Accessed November 11, 2020."},{"issue":"1","key":"10.1016\/j.idc.2020.10.003_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.idc.2008.10.003","article-title":"Host defense and pathogenesis in Staphylococcus aureus infections","volume":"23","author":"DeLeo","year":"2009","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.ajpath.2014.11.030","article-title":"Pathogenesis of Staphylococcus aureus abscesses","volume":"185","author":"Kobayashi","year":"2015","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11908-013-0364-y","article-title":"Does the nose know? An update on MRSA decolonization strategies","volume":"15","author":"Abad","year":"2013","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.amjmed.2007.07.034","article-title":"The risk of infection after nasal colonization with Staphylococcus aureus","volume":"121","author":"Safdar","year":"2008","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.idc.2020.10.003_bib7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/cid\/cis213","article-title":"Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology","volume":"54","author":"Miller","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.003_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/br.27.1.56-71.1963","article-title":"Healthy carriage of Staphylococcus aureus: its prevalence and importance","volume":"27","author":"Williams","year":"1963","journal-title":"Bacteriol Rev"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/669095","article-title":"Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission","volume":"34","author":"McKinnell","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2020.10.003_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2334-14-296","article-title":"Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009","volume":"14","author":"Suaya","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/cir308","article-title":"Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008","volume":"53","author":"Talan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.003_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12879-015-1071-0","article-title":"Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010","volume":"15","author":"Miller","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.003_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(12)70238-4","article-title":"The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis","volume":"13","author":"Shallcross","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2020.10.003_bib15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1086\/523581","article-title":"In\u00a0vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections","volume":"45","author":"Hamilton","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.003_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.diagmicrobio.2013.02.020","article-title":"Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus","volume":"76","author":"Ray","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2020.10.003_bib17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1086\/654007","article-title":"Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score","volume":"31","author":"Lipsky","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0950268809990483","article-title":"Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review","volume":"138","author":"Chira","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation","volume":"89","author":"Jeng","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib20","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1017\/S0950268812002634","article-title":"A\u00a0comparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains","volume":"141","author":"Eells","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3947\/ic.2017.49.2.158","article-title":"Community-associated methicillin-resistant Staphylococcus aureus in nosocomial infections","volume":"49","author":"Choo","year":"2017","journal-title":"Infect Chemother"},{"issue":"1","key":"10.1016\/j.idc.2020.10.003_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrobial Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2020.10.003_bib23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1716771","article-title":"Decolonization to reduce postdischarge infection risk among MRSA carriers","volume":"380","author":"Huang","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib24","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1128\/JCM.00134-12","article-title":"Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization","volume":"50","author":"Ray","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2020.10.003_bib25","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S1198-743X(16)30095-7","article-title":"Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections","volume":"22","author":"Russo","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMcp070747","article-title":"Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus","volume":"357","author":"Daum","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib27","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.003_bib28","first-page":"CD003261","article-title":"Interventions for impetigo","volume":"1","author":"Koning","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2020.10.003_bib29","author":"Edge"},{"issue":"9960","key":"10.1016\/j.idc.2020.10.003_bib30","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(14)60841-2","article-title":"Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial","volume":"384","author":"Bowen","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib31","first-page":"148","article-title":"A\u00a0systematic review of bacteremias in cellulitis and erysipelas","volume":"64","author":"Gunderson","year":"2012","journal-title":"J\u00a0Infect"},{"issue":"12","key":"10.1016\/j.idc.2020.10.003_bib32","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.idc.2020.10.003_bib33","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2017.5653","article-title":"Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial","volume":"317","author":"Moran","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib34","doi-asserted-by":"crossref","first-page":"e013260","DOI":"10.1136\/bmjopen-2016-013260","article-title":"Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis","volume":"7","author":"Brindle","year":"2017","journal-title":"BMJ Open"},{"issue":"14","key":"10.1016\/j.idc.2020.10.003_bib35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib36","first-page":"335","article-title":"Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the community","volume":"40","author":"Lee","year":"2007","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.idc.2020.10.003_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National healthcare safety network at the centers for disease control and prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib38","first-page":"210","article-title":"Predictors of a positive duplex scan in patients with a clinical presentation compatible with deep vein thrombosis or cellulitis","volume":"14","author":"Rabuka","year":"2003","journal-title":"Can J Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D39GN050RR","article-title":"Diagnostic accuracy in patients admitted to hospitals with cellulitis","volume":"17","author":"David","year":"2011","journal-title":"Dermatol Online J"},{"issue":"7","key":"10.1016\/j.idc.2020.10.003_bib40","first-page":"437","article-title":"C-reactive protein as an indicator of bacterial infection of adult patients in the emergency department","volume":"25","author":"Chan","year":"2002","journal-title":"Chang Gung Med J"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10096-006-0186-z","article-title":"Risk factors for bacteremia in patients with limb cellulitis","volume":"25","author":"Peralta","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib42","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/313525","article-title":"Cost-effectiveness of blood cultures for adult patients with cellulitis","volume":"29","author":"Perl","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib43","first-page":"384","article-title":"The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department","volume":"13","author":"Tayal","year":"2006","journal-title":"Acad Emerg Med"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiology.192.2.8029421","article-title":"MR imaging in acute infectious cellulitis","volume":"192","author":"Rahmouni","year":"1994","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jid.2017.09.022","article-title":"Skin surface temperatures measured by thermal imaging aid in the diagnosis of cellulitis","volume":"138","author":"Ko","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib46","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmi.2017.08.028","article-title":"Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis","volume":"24","author":"Agarwal","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.idc.2020.10.003_bib48","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"Daptomycin 98-01 and 99-01 Investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2020.10.003_bib49","first-page":"iv53","article-title":"CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections","volume":"65","author":"Wilcox","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1086\/511872","article-title":"Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome","volume":"44","author":"Ruhe","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.003_bib51","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamainternmed.2016.3646","article-title":"The new antibiotic mantra-\"shorter is better\"","volume":"176","author":"Spellberg","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.idc.2020.10.003_bib52","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5\u00a0days) and standard (10\u00a0days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2020.10.003_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6\u00a0days versus linezolid for 10\u00a0days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2020.10.003_bib54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpeds.2015.10.044","article-title":"Trimethoprim-sulfamethoxazole therapy reduces failure and recurrence in methicillin-resistant Staphylococcus aureus skin abscesses after surgical drainage","volume":"169","author":"Holmes","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2020.10.003_bib55","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.cmi.2015.01.011","article-title":"Comparison of vancomycin and linezolid in patients with peripheral vascular disease and\/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus","volume":"21","author":"Eckmann","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib56","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/cem.2014.52","article-title":"The role of adjunctive antibiotics in the treatment of skin and soft tissue abscesses: a systematic review and meta-analysis","volume":"17","author":"Fahimi","year":"2015","journal-title":"CJEM"},{"issue":"9","key":"10.1016\/j.idc.2020.10.003_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1507476","article-title":"Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess","volume":"374","author":"Talan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.idc.2020.10.003_bib58","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1607033","article-title":"A\u00a0placebo-controlled trial of antibiotics for smaller skin abscesses","volume":"376","author":"Daum","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2020.10.003_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.annemergmed.2017.07.483","article-title":"Subgroup analysis of antibiotic treatment for skin abscesses","volume":"71","author":"Talan","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.idc.2020.10.003_bib60","article-title":"Antibiotic duration, but not abscess size, impacts clinical cure of limited skin and soft tissue infection after incision and drainage","author":"Lake","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2020.10.003_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1403789","article-title":"Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections","volume":"372","author":"Miller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2020.10.003_bib62","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY antimicrobial surveillance program","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2020.10.003_bib63","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JCM.02195-12","article-title":"Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?","volume":"50","author":"Bowen","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.idc.2020.10.003_bib65","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/cid\/cix754","article-title":"Impact of systemic antibiotics on Staphylococcus aureus colonization and recurrent skin infection","volume":"66","author":"Hogan","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.003_bib67","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/377501","article-title":"Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in\u00a0vitro","volume":"37","author":"Siberry","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib68","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/598510","article-title":"Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300","volume":"48","author":"Schwartz","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib69","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline, and doxycycline","volume":"133","author":"Shapiro","year":"1997","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib70","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/429628","article-title":"Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature","volume":"40","author":"Ruhe","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2020.10.003_bib71","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.00206-07","article-title":"Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus","volume":"51","author":"Cenizal","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"issue":"10121","key":"10.1016\/j.idc.2020.10.003_bib72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.idc.2020.10.003_bib73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2020.10.003_bib74","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0924-8579(98)00075-2","article-title":"Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus","volume":"12","author":"Whitby","year":"1999","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.idc.2020.10.003_bib75","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/jac\/dkq094","article-title":"Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)","volume":"65","author":"Castanheira","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 7","key":"10.1016\/j.idc.2020.10.003_bib76","doi-asserted-by":"crossref","first-page":"S520","DOI":"10.1093\/cid\/cir167","article-title":"A\u00a0randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections","volume":"52","author":"Craft","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijantimicag.2005.09.003","article-title":"Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA)","volume":"26","author":"Itani","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idc.2020.10.003_bib78","first-page":"857","article-title":"New developments in the management of severe skin and deep skin structure infections - focus on tedizolid","volume":"11","author":"Durkin","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"10.1016\/j.idc.2020.10.003_bib79","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/cid\/ciy165","article-title":"A\u00a0Comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study","volume":"67","author":"O\u2019Riordan","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","article-title":"Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent","volume":"80","author":"Zhanel","year":"2020","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib83","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/AAC.01066-13","article-title":"Mechanism of action of the novel aminomethylcycline antibiotic omadacycline","volume":"58","author":"Draper","year":"2014","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJMoa1800170","article-title":"Omadacycline for acute bacterial skin and skin-structure infections","volume":"380","author":"O\u2019Riordan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib85","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(19)30275-0","article-title":"Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial","volume":"19","author":"O\u2019Riordan","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib86","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/phar.2376","volume":"40","author":"Rybak","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib87","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid","volume":"26","author":"Stein","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"10.1016\/j.idc.2020.10.003_bib88","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/cid\/civ462","article-title":"Vancomycin combined with clindamycin for the treatment of acute bacterial skin and skin-structure infections","volume":"61","author":"Wargo","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2020.10.003_bib89","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1086\/587896","article-title":"Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2020.10.003_bib90","doi-asserted-by":"crossref","first-page":"e41870","DOI":"10.1371\/journal.pone.0041870","article-title":"Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis","volume":"7","author":"Polyzos","year":"2012","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.idc.2020.10.003_bib91","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.idc.2020.10.003_bib92","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/497271","article-title":"Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections","volume":"41","author":"Jauregui","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib93","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A\u00a0randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.003_bib94","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/ciu778","article-title":"Single-dose oritavancin versus 7-10\u00a0days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib95","doi-asserted-by":"crossref","first-page":"e004744","DOI":"10.1136\/bmjopen-2013-004744","article-title":"The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials","volume":"4","author":"Wang","year":"2014","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.idc.2020.10.003_bib96","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/cid\/ciy287","article-title":"Effect of statin coadministration on the risk of daptomycin-associated myopathy","volume":"67","author":"Dare","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib97","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib98","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijid.2005.05.003","article-title":"Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial","volume":"9","author":"Sacchidanand","year":"2005","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/511033","article-title":"Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation","volume":"44","author":"Miller","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.003_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciu301","article-title":"Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting","volume":"59","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.003_bib101","doi-asserted-by":"crossref","first-page":"ofy123","DOI":"10.1093\/ofid\/ofy123","article-title":"The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"5","author":"Miller","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib102","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/AAC.02626-15","article-title":"Relationship between adherence to oral antibiotics and postdischarge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections","volume":"60","author":"Eells","year":"2016","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2020.10.003_bib103","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02239-18","article-title":"In\u00a0vitro activity of iclaprim against isolates in two phase 3 clinical trials (REVIVE-1 and -2) for acute bacterial skin and skin structure infections","volume":"63","author":"Noviello","year":"2019","journal-title":"Antimicrobial Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02580-17","volume":"62","author":"Holland","year":"2018","journal-title":"Antimicrobial Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2020.10.003_bib105","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix987","volume":"66","author":"Huang","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.003_bib106","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1128\/AAC.02106-12","article-title":"Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections","volume":"57","author":"Prince","year":"2013","journal-title":"Antimicrobial Agents Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552020300829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:18:34Z","timestamp":1760195914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552020300829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0891552020300829"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.003","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staphylococcal Skin and Soft Tissue Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}